![Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/037/269/small/pharmaceuticals-biotechnology-pharma-biotech-resources.jpg)
Summary: Ansgar Hebborn, Head of the Global Payer & HTA Program Policy at F Hoffmann-La Roche, joins Tim Haïdar from Pharma IQ, to analyse major trends and implications for the research-based pharmaceutical industry. Firstly he sums up who decides on what constitutes value in